Psychofarm Podcast

Mood stabilizers for bipolar disorder can be confusing because lithium, lamotrigine, Depakote, carbamazepine, and oxcarbazepine have very different strengths, risks, and clinical roles. In this episode, two psychiatrists break down how they think about maintenance treatment, lithium dosing and monitoring, common side effects, lab levels, toxicity counseling, and medication interactions. They also compare Depakote for mania, lamotrigine for bipolar depression, carbamazepine’s interaction burden, and the potential role of oxcarbazepine. Along the way, they discuss combination treatment, diagnostic uncertainty, pregnancy and fertility considerations, rash counseling, and why effective bipolar care requires focusing on long-term episode prevention rather than the symptom of the day.


This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit psychofarm.substack.com

Bipolar disorder treatment is put to the test in this clinically grounded tier list with psychiatrist Jim Phelps. He and Dr. Malzberg rank low-dose lithium, lamotrigine, social rhythm therapy, dark therapy, dawn simulators, antidepressants, carbamazepine, supplements, ketogenic diet, mood tracking, and group psychoeducation. Along the way, they discuss why sleep and circadian rhythm belong in the mood stabilizer conversation, how antidepressants may worsen cycling or mixed states, and why the long-term goal is not simply treating the mood of the day. The episode also explores practical adherence, bipolar comorbidity, passive sleep tracking, and underused nonmedication approaches.
Dr. Phelps’ YouTube: https://www.youtube.com/@psycheducation


This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit psychofarm.substack.com

Anxiety medications tier list: two psychiatrists rank the treatments they actually use for generalized anxiety disorder… and the ones they avoid. The discussion covers first-line SSRIs, why buspirone may be underrated, when benzodiazepines can help or harm, and how to think about mirtazapine, hydroxyzine, propranolol, gabapentin, pregabalin, quetiapine, and bupropion. Just as important, the episode argues that “anxiety” is not a diagnosis: re-diagnosis, mindfulness, CBT and ACT principles, exercise, reducing caffeine or stimulants, and understanding avoidance may matter more than adding another prescription. The result is a practical, opinionated guide to anxiety treatment that combines evidence, clinical experience, side effects, dependence risk, and long-term recovery.


This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit psychofarm.substack.com

Psychodynamic therapy interventions are the focus of this episode, organized through a practical levels framework for clinicians. Dr. Fu and Dr. Greg break down empathic mirroring as a way to keep the patient’s narrative moving, clarification as a tool for deepening detail, confrontation as a gentle way to point out patterns or discrepancies, and interpretation as the rare intervention that should come only after enough groundwork. Along the way, they connect these skills to diagnostic interviewing, medication management, forensic psychiatry, therapeutic alliance, and the difference between helping a patient talk more and pushing too quickly toward insight.


This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit psychofarm.substack.com

Unfortunately no Dr. Fu today, but Dr. Malzberg speaks with the wonderful psychiatrist Dr. Mary Ellen Eller, who walks through what modern electroconvulsive therapy actually looks like and when clinicians should consider it. The episode covers ECT history, stigma, seizure monitoring, memory concerns, side effects, and the real-world logistics patients face during a treatment course. It also explores where ECT fits in the algorithm for severe depression, depression with psychosis, catatonia, bipolar mania. The result is a grounded, clinician-friendly guide to a misunderstood treatment.


This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit psychofarm.substack.com